APA

Mato A. R., Hill B. T., Lamanna N., Barr P. M., Ujjani C. S., Brander D. M., Howlett C., Skarbnik A. P., Cheson B. D., Zent C. S., Pu J. J., Kiselev P., Foon K., Lenhart J., Henick Bachow S., Winter A. M., Cruz A., Claxton D. F., Goy A., Daniel C., Isaac K., Kennard K. H., Timlin C., Fanning M., Gashonia L., Yacur M., Svoboda J., Schuster S. J. & Nabhan C. (20180302). Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Mato A R, Hill B T, Lamanna N, Barr P M, Ujjani C S, Brander D M, Howlett C, Skarbnik A P, Cheson B D, Zent C S, Pu J J, Kiselev P, Foon K, Lenhart J, Henick Bachow S, Winter A M, Cruz A-L, Claxton D F, Goy A, Daniel C, Isaac K, Kennard K H, Timlin C, Fanning M, Gashonia L, Yacur M, Svoboda J, Schuster S J and Nabhan C. 20180302. Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Mato A. R., Hill B. T., Lamanna N., Barr P. M., Ujjani C. S., Brander D. M., Howlett C., Skarbnik A. P., Cheson B. D., Zent C. S., Pu J. J., Kiselev P., Foon K., Lenhart J., Henick Bachow S., Winter A. M., Cruz A., Claxton D. F., Goy A., Daniel C., Isaac K., Kennard K. H., Timlin C., Fanning M., Gashonia L., Yacur M., Svoboda J., Schuster S. J. and Nabhan C. (20180302). Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Mato A R, Hill B T, Lamanna N, Barr P M, Ujjani C S, Brander D M, Howlett C, Skarbnik A P, Cheson B D, Zent C S, Pu J J, Kiselev P, Foon K, Lenhart J, Henick Bachow S, Winter A M, Cruz A-L, Claxton D F, Goy A, Daniel C, Isaac K, Kennard K H, Timlin C, Fanning M, Gashonia L, Yacur M, Svoboda J, Schuster S J and Nabhan C. Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients. : Annals of oncology : official journal of the European Society for Medical Oncology. 20180302.